Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Evotec and Harvard University form new alliance

Jan. 17, 2012

Trillium set to begin phase I TTI-1612 trial in Canada

Dec. 19, 2011

FDA approves new oxybutynin gel product

Dec. 12, 2011

ChemoCentryx begins new study of CCX-140 in diabetic nephropathy

Dec. 9, 2011

Primary endpoint met in Toviaz trial

Dec. 9, 2011

Spectrum Pharmaceuticals files IND with FDA for phosphate-binding agent

Dec. 7, 2011

New triterpenoid derivatives prepared by Concert Pharmaceuticals

Dec. 7, 2011

Novel mineralocorticoid receptor antagonists prepared by Pfizer

Dec. 5, 2011

Novartis discloses final results from EXIST-2 trial

Nov. 30, 2011

Phase III data support lixivaptan therapy in euvolemic hyponatremia

Nov. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...